A red splotch forms where most preschoolers get their fifth, and last, shot of the acellular diphtheria-tetanus-pertussis (DTaP) vaccine, and it can last a few days. Neither of two common over-the-counter drugs - ibuprofen (Advil) and acetamino
Obese people may be more sensitive to pain than people who aren't obese, a new study suggests. All of the older adults who completed the study had osteoarthritis of the knee, a disease that causes inflammation and extreme pain in the knees.
Researchers at the University of Pennsylvania School of Medicine have found that leaving a mildly underactive thyroid gland (subclinical hypothyroidism) untreated does not lead to increased cardiova
Having an overactive thyroid gland is linked with an increased risk for atrial fibrillation (a type of abnormal heart rhythm), but neither an over- or under active thyroid gland is associated with a higher risk for other cardiovascular problems or incr
Therapy that involved bone marrow stem cells did not improve cardiac function in patients following a heart attack, according to a study in the March 1 issue of JAMA: The Journal of the American Medical
A study by a University at Buffalo pediatric researcher investigating the causes of weight gain in children after they have their tonsils and adenoids removed to treat sleep-disordered breathing has s
Concussion patients with a normal head CT scan may believe they are free of brain injury, but CT scans often miss damage at the molecular level, warns a University of Rochester Medical Center s
Attaching a recently discovered cytokine to neural stem cells derived from bone marrow, researchers at Cedars-Sinai Medical Center's Maxine D
C-reactive protein (CRP), a biomarker for inflammation in the blood, can help to identify individuals whose abnormal precancerous lesions will advance closer to invasive lung cancer. The results appear in the first issue for March 2005 of the
Exposure to toxic elements leads to worrying health problems in many parts of the world, including Europe. A new, EU-funded research project, involving partners from all over the world, will study the health effects of long-term, low-level expo
Date: Wednesday, 3-May-2006
Percutaneous cryoablation, a relatively non-invasive technique that destroys tumors by freezing them, is a safe method for treating kidney tumors in selected patients who are not considered candidates for surgery, according to a new study by researchers from the Mayo Clinic in Rochester, MN.For the study, researchers treated 59 kidney tumors in 58 patients using percutaneous (through the skin) cryoablation. The researchers found that the tumors were destroyed in 57 of the 59 cases.
After an average follow-up of nine months for the 42 tumors that were available to the researchers, no tumor progression was found. The traditional treatment for worrisome kidney tumors has been surgery, according to the researchers. "A relative drawback of surgery is its invasiveness, where a large incision or several smaller incisions are required. Recovery for surgery may be prolonged, on the order of weeks. In contrast, percutaneous cryoablation is performed through small nicks in the skin, and the patient is dismissed from the hospital within 24 hours with a few band-aids," said Thomas Atwell, MD, one of the authors of the study.
Percutaneous cryoablation is performed while the patient is under general anesthesia. Using real-time ultrasound for guidance, one or more cryoprobes are placed through the skin into the kidney tumor. The tumor is then frozen over the course of about 30 minutes. "We can literally watch the evolving ice-ball grow from the cryoprobes and encompass the tumor. The freezing temperatures destroy the tumor cells and, based on short-term follow-up, results in complete destruction of the tumor in over 95% of cases," said Dr. Atwell.
However, say the researchers, not all tumors are amenable to cryoablation, usually because the tumor lies too close to critical abdominal organs that could be injured by the ice-ball or because of the tumor's size. For this study, the researchers were able to treat tumors up to 7 cm in size. "Based on our early experience, percutaneous kidney cryoablation appears to provide an important alternative method of kidney tumor treatment for select patients. Longer term follow-up will be necessary to determine true treatment durability," said Dr. Atwell.
The full results of the study were presented on Monday, May 1, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.
http://www.arrs.org